山河药辅：四季度公司微晶纤维素等主要产品订单充足，价格保持稳定

Group 1 - The company reported that it has sufficient orders for its main product, microcrystalline cellulose, in the fourth quarter, and prices remain stable, indicating a good production and operational status [1] - The loss experienced in the fourth quarter of the previous year was due to goodwill impairment losses, which will not occur this year [1]